(Q35196714)

7 August 2017

1 reference

title

Where do we stand with hepatoblastoma? A review (English)

1 reference

7 August 2017

author

Dietrich von Schweinitz

4

object named as

Dietrich von Schweinitz

0 references

author name string

J Marco Schnater

1

1 reference

7 August 2017

S Eleonore Köhler

2

1 reference

7 August 2017

Wouter H Lamers

3

1 reference

7 August 2017

Dietrich von Schweinitz

4

1 reference

7 August 2017

Daniël C Aronson

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

98

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

668-678

1 reference

Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of pediatrics surgical section survey — 1974

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Primary liver tumours in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatoblastoma in children: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Childhood cancers: hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Malignant hepatic tumours in children: incidence, clinical features and aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Primary liver tumors in infancy and childhood. 41 cases variously treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Association between hepatoblastoma and very low birth weight: a trend or a chance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatoblastoma and low birth weight: a trend or chance observation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Prognostic impact of molecular genetic alterations in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Stem-like cells in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Production of interleukin-1 beta and interleukin-6 in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Risk of hepatoblastoma in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Epidemiological and familial aspects of hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Neonatal hepatoblastoma metastatic to the choroid and iris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Periportal low attenuation at CT in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Hepatoblastoma: assessment of criteria for histologic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Orthotopic liver transplantation for unresectable hepatoblastoma: a single center's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Feasibility and toxicity of chemoembolization for children with liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

A 10-year experience of pediatric brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

Constitutional interstitial deletion of 11p11 and pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Cytogenetic characterization of childhood hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Cytogenetic findings in two new cases of hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Loss of heterozygosity on chromosome 1 in human hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Mutation analysis of p53 gene in childhood malignant solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Is there a place for radiation therapy in the management of hepatoblastomas and hepatocellular carcinomas in children?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Identification of risk groups in hepatoblastoma--another step in optimising therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Extramedullary hematopoiesis and intratumoral production of cytokines in childhood hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Human hepatocyte growth factor stimulates the growth of HuH-6 clone 5 human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

The occurrence of liver growth factor in hepatoblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

High frequency of beta-catenin mutations in hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Ultrasound of primary hepatic tumours in childhood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Potentially misleading bone scan findings in patients with hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Prognostic factors and staging systems in childhood hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Proceedings of an international research workshop on pediatric liver tumours, 18-20 March 1999, Berne, Switzerland. Into the year 2000

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Successful transplantation of human hepatoblastoma into immunodeficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Hepatoblastoma: The Prognostic Significance of Histologic Type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Clinico-pathological criteria with prognostic relevance in hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Small cell undifferentiated histology in hepatoblastoma may be unfavorable

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Liver Transplantation for Hepatoblastoma The American Experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Unresectable hepatic tumors in childhood and the role of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11585

7 January 2021

Identifiers

DOI

10.1002/CNCR.11585

1 reference

7 August 2017

1 reference